Latest Report Available at Orbis research Mammography
Screening Market provides pin-point analysis for changing competitive dynamics
and a forward looking perspective on different factors driving or restraining
industry growth.
Request sample
copy of this report @ http://www.orbisresearch.com/contacts/request-sample/387965 .
United States
mammography screening market is expected to reach more than US$ 5.4 Billion by
2022.
Market growth can be attributed to factors such as increasing incidence of breast cancer, increasing awareness related to early breast cancer detection, growing government investments and funding for breast cancer screening, technological advancement in mammography technologies and implementation of several initiatives to create awareness about the early detection of breast cancer.
Market growth can be attributed to factors such as increasing incidence of breast cancer, increasing awareness related to early breast cancer detection, growing government investments and funding for breast cancer screening, technological advancement in mammography technologies and implementation of several initiatives to create awareness about the early detection of breast cancer.
“Mammography Screening Market Outlook 2022: United States Opportunity
and Demand Analysis, Market Forecast 2017-2022” provides a deep and thorough
evaluation of the United States mammography screening market. The report
provides an in–depth analysis of the breast cancer invasive, in situ and men
cases and added breast cancer death figures of both men and women in United
States. Furthermore, the report also covered mammography screening population
from 2010 to 2022.
Purchase a copy
of Mammography Screening Market visit @ http://www.orbisresearch.com/contact/purchase/387965
For more information contact sales@orbisresearch.com .
Market outlook in value terms has been analyzed based on historical,
current and potential trends and the market is projected from 2017 to 2022.
Additionally, the report includes assessment of breast cancer clinical trials
and mammography reimbursement pattern. The report also explores detailed
description of growth drivers and inhibitors of the United States mammography
screening market.
The report concludes
with the profiles of major manufacturers of mammography system such as Hologic, Siemen
Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation and GE
Healthcare. The major manufacturers are evaluated on parameters such as
business overview and mammography marketed products.
Key Topics
Covered in the Report
United States Breast Cancer Cases (2010 - 2022)
United States Breast Cancer Mammography Screening Population (2010 – 2022)
United States Breast Cancer Death (2010 – 2017)
Market Overview: United States Mammography Screening (2010 – 2022)
Reimbursement Policies of the United States Breast Cancer Screening
Breast Cancer Screening Clinical Trail Insight by Phase, Company & Country
Key Drivers and Inhibitors of the United States Mammography Screening Market
Key Manufacturers Analysis
United States Breast Cancer Cases (2010 - 2022)
United States Breast Cancer Mammography Screening Population (2010 – 2022)
United States Breast Cancer Death (2010 – 2017)
Market Overview: United States Mammography Screening (2010 – 2022)
Reimbursement Policies of the United States Breast Cancer Screening
Breast Cancer Screening Clinical Trail Insight by Phase, Company & Country
Key Drivers and Inhibitors of the United States Mammography Screening Market
Key Manufacturers Analysis
Major Companies
Covered in this Report:
Hologic
Siemen Healthineers
Philips Healthcare
GE Healthcare
Toshiba Medical Systems Corporation
Hologic
Siemen Healthineers
Philips Healthcare
GE Healthcare
Toshiba Medical Systems Corporation
Browse Complete
Report @ http://www.orbisresearch.com/reports/index/united-states-breast-cancer-screening-market-analysis-by-type-share-cases-clinical-trials-insight-reimbursement-competitive-strategies-and-forecast-2017-2022 .
Some points from TOC:
1. Executive Summary
2. Breast Cancer Facts
3. United States Breast Cancer Cases & Population (2010
– 2022)
3.1 Breast Cancer Mammography Screening Population (2010 – 2022)
3.2 Breast Cancer Occurrence (2010 – 2022)
3.2.1 Total Breast Cancer Cases
3.2.1.1 Breast Cancer Invasive Cases
3.2.1.2 Breast Cancer In Situ Cases
3.2.1.3 Breast Cancer Men Cases
3.3 Breast Cancer Death (2010 – 2017)
3.3.1 Total Breast Cancer Death
3.3.1.1 Women Breast Cancer Death
3.3.1.2 Men Breast Cancer Death
3.1 Breast Cancer Mammography Screening Population (2010 – 2022)
3.2 Breast Cancer Occurrence (2010 – 2022)
3.2.1 Total Breast Cancer Cases
3.2.1.1 Breast Cancer Invasive Cases
3.2.1.2 Breast Cancer In Situ Cases
3.2.1.3 Breast Cancer Men Cases
3.3 Breast Cancer Death (2010 – 2017)
3.3.1 Total Breast Cancer Death
3.3.1.1 Women Breast Cancer Death
3.3.1.2 Men Breast Cancer Death
4. Market Overview: United States Mammography Screening
(2010 – 2022)
5. Key Drivers and Inhibitors of the United States
Mammography Screening Market
5.1 Market Drivers
5.2 Market Inhibitors
5.1 Market Drivers
5.2 Market Inhibitors
6. Reimbursement Policies of the United States Mammography
Screening
7. Breast Cancer Screening Clinical Trail Insight by Phase,
Company & Country
7.1 Year 2017
7.2 Year 2016
7.3 Year 2015
7.1 Year 2017
7.2 Year 2016
7.3 Year 2015
8. Key Manufacturers Analysis
8.1 Hologic
8.1.1 Business Overview
8.1.2 Mammography – Marketed Products
8.2 Siemens Healthineers
8.2.1 Business Overview
8.2.2 Mammography – Marketed Products
8.3 Philips Healthcare
8.3.1 Business Overview
8.3.2 Mammography – Marketed Products
8.4 Toshiba Medical Systems Corporation
8.4.1 Business Overview
8.4.2 Mammography – Marketed Products
8.5 GE Healthcare
8.5.1 Business Overview
8.5.2 Mammography – Marketed Products
8.1 Hologic
8.1.1 Business Overview
8.1.2 Mammography – Marketed Products
8.2 Siemens Healthineers
8.2.1 Business Overview
8.2.2 Mammography – Marketed Products
8.3 Philips Healthcare
8.3.1 Business Overview
8.3.2 Mammography – Marketed Products
8.4 Toshiba Medical Systems Corporation
8.4.1 Business Overview
8.4.2 Mammography – Marketed Products
8.5 GE Healthcare
8.5.1 Business Overview
8.5.2 Mammography – Marketed Products
List Of Tables:
List of Figures:
Figure 3–1: United States – Breast Cancer Mammography Screening Population(Thousand),2010 – 2016
Figure 3–2: United States – Breast Cancer Mammography Screening Population(Thousand),2017 – 2022
Figure 3–3: United States – Total Breast Cancer Cases(Number),2010 – 2016
Figure 3–4: United States – Forecast for Total Breast Cancer Cases(Number),2017 – 2022
Figure 3–5: United States – Breast Cancer Invasive Cases(Number),2010 – 2016
Figure 3–6: United States – Forecast for Breast Cancer Invasive Cases(Number),2017 – 2022
Figure 3–7: United States – Breast Cancer In Situ Cases(Number),2010 – 2016
Figure 3–8: United States – Forecast for Breast Cancer In Situ Cases(Number),2017 – 2022
Figure 3–9: United States – Breast Cancer Men Cases(Number),2010 – 2016
Figure 3–10: United States – Forecast for Breast Cancer Men Cases(Number),2017 – 2022
Figure 3–11: United States – Total Breast Cancer Death(Number),2010 – 2017
Figure 3–12: United States – Women Breast Cancer Death(Number),2010 – 2017
Figure 3–13: United States – Men Breast Cancer Death(Number),2010 – 2017
Figure 6–1: United States – Mammography Screening Market (Million US$),2010 – 2016
Figure 6–2: United States – Forecast for Mammography Screening Market (Million US$),2017 – 2022
Figure 3–1: United States – Breast Cancer Mammography Screening Population(Thousand),2010 – 2016
Figure 3–2: United States – Breast Cancer Mammography Screening Population(Thousand),2017 – 2022
Figure 3–3: United States – Total Breast Cancer Cases(Number),2010 – 2016
Figure 3–4: United States – Forecast for Total Breast Cancer Cases(Number),2017 – 2022
Figure 3–5: United States – Breast Cancer Invasive Cases(Number),2010 – 2016
Figure 3–6: United States – Forecast for Breast Cancer Invasive Cases(Number),2017 – 2022
Figure 3–7: United States – Breast Cancer In Situ Cases(Number),2010 – 2016
Figure 3–8: United States – Forecast for Breast Cancer In Situ Cases(Number),2017 – 2022
Figure 3–9: United States – Breast Cancer Men Cases(Number),2010 – 2016
Figure 3–10: United States – Forecast for Breast Cancer Men Cases(Number),2017 – 2022
Figure 3–11: United States – Total Breast Cancer Death(Number),2010 – 2017
Figure 3–12: United States – Women Breast Cancer Death(Number),2010 – 2017
Figure 3–13: United States – Men Breast Cancer Death(Number),2010 – 2017
Figure 6–1: United States – Mammography Screening Market (Million US$),2010 – 2016
Figure 6–2: United States – Forecast for Mammography Screening Market (Million US$),2017 – 2022
For any enquires before buying, connect
with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a single point aid
for all your market research requirements. We have vast database of reports
from the leading publishers and authors across the globe. We specialize in
delivering customized reports as per the requirements of our clients. We have
complete information about our publishers and hence are sure about the accuracy
of the industries and verticals of their specialization. This helps our clients
to map their needs and we produce the perfect required market research study
for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214)
884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115
No comments:
Post a Comment